The US Bankruptcy Court gave an order approving the sale certain assets of INSYS Therapeutics, Inc. on December 16, 2019. The debtor has been authorized to sell its certain assets to Renaissance Lakewood, LLC, for a purchase price of $0.25 million. The debtor’s assets include equipment, records and copies of all data or information in debtor possession that is reasonably necessary for buyer’s use of the Equipment to manufacture pharmaceutical products. The debtor did not receive any other competing bids for the purchase of its assets and therefore Renaissance Lakewood, LLC emerged as the winning bidder.